Quantcast

Latest high-throughput screening Stories

2011-10-07 07:00:00

Blue Sky announced the appointment of Dr. Kelvin Lam as Vice President, Assay Services. Dr. Lam joins Blue Sky with more than 18 years of experience in High Throughput Screening (HTS) and High Content Screening (HCS) of small molecule and natural products. (PRWEB) October 07, 2011 Blue Sky announced the appointment of Dr. Kelvin Lam as Vice President, Assay Services. Dr. Lam joins Blue Sky with more than 18 years of experience in High Throughput Screening (HTS) and High Content Screening...

2011-08-05 12:06:01

Possible resistance-proof drug pairs found by NIH scientists Numerous potential anti-malarial candidate drugs have been uncovered by investigators from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI), both parts of the National Institutes of Health (NIH). Researchers at the NIH Chemical Genomics Center, administered by NHGRI, used robotic, ultra-high-throughput screening technology to test more than 2,800 chemical...

2011-06-22 06:50:00

HAMILTON, N.J., June 22, 2011 /PRNewswire/ -- VENENUM Biodesign, a drug discovery company that utilizes ultra-high throughput screening (UHTS) of its compound collection to identify potential therapeutic agents against its novel disease-based targets, or its partners' targets, announced today that it opened its new medicinal chemistry space at 8 Black Forest Road in Hamilton, NJ. The facility comprises over 11,000 square feet of state-of-the-art research laboratories and office space. The...

2011-05-04 07:15:00

VINELAND, N.J., May 4, 2011 /PRNewswire/ -- Designed for analytical research and clinical diagnostic testing, Laboratory Supply Distributors Corp. announces the 96-Well Multi-Tier(TM) Micro Plate System. Its unique, patented design allows for more flexibility and ease of use. An improvement on existing 96-Well systems, the Multi-Tier Plate can be built using spacers to hold vial capacities of 0.5ml, 1.0ml, 1.5ml and 2.0ml depending on the height limitations of the instrument. Replacement...

2011-04-15 00:00:28

BellBrook Labs has developed a new HTS assay for screening methyltransferases, the family of enzymes involved in epigenetic modifications that cause cancerous cell growth and metastasis. The innovative EPIGEN Methyltransferase Assay combines proprietary coupling enzymes with the detection module of the extensively validated Transcreener® HTS Assay platform to advance the discovery of new anti-cancer therapeutics. Madison, WI (PRWEB) April 14, 2011 BellBrook Labs today introduced an...

2011-03-30 00:00:28

UT Southwestern Medical Center capitalizing on Genedata Screener for simultaneous processing of multiple dose-response curve assays in all types of cancer research projects Orlando, FL (PRWEB) March 28, 2011 Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata Screener® 9 for high-throughput screening and high-content screening is used by UT Southwestern Medical Center in Dallas, Texas. Among its features,...

2011-03-22 06:55:00

HAMILTON, N.J., March 22, 2011 /PRNewswire/ -- VENENUM Biodesign, a drug discovery company that utilizes ultra-high throughput screening (UHTS) of its compound collection to identify hits against its novel disease-based targets or its partners' targets, announced today that it will be exhibiting at the 17th SBS Annual Conference & Exhibition at the Gaylord Palms Resort and Convention Center in Orlando, Florida, March 27-31, 2011. VENENUM Biodesign will be exhibiting at booth #524....

2011-03-02 00:00:27

BellBrook Labs has developed a miniaturized high content assay for neutrophil chemotaxis in a stable gradient using its proprietary iuvoâ“ž¢ Microconduit Array platform. The results of this research, recently published in the Journal of Immunological Methods, showcase the ability of BellBrook's iuvoâ“ž¢ Chemotaxis Assay to advance the exploration of new targets for anti-inflammatory drug development. Madison, WI (PRWEB) March 1, 2011...

2011-01-05 07:10:00

SAN RAMON, Calif., Jan. 5, 2011 /PRNewswire/ -- Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,855,167. The invention describes technologies and high-throughput methods for identifying bimolecular interactions in vivo based on protein-fragment complementation assays (PCA). The patent, the eighteenth assigned to Odyssey Thera, further protects assays utilizing fragments of inherently fluorescent proteins, and the use of...

2011-01-04 10:20:00

HAMILTON, N.J., Jan. 4, 2011 /PRNewswire/ -- VENENUM Biodesign, a drug discovery company that utilizes ultra-high throughput screening (UHTS) of its compound collection to identify hits against its novel disease-based targets or its partners' targets, announced today its relocation to a brand-new, state-of-the-art facility in Hamilton, NJ in Mercer County. VENENUM Biodesign was established with the mission to improve patients' lives through the discovery of new therapeutic compounds. They...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related